AI assistant
Sending…
SPRUCE BIOSCIENCES, INC. — Director's Dealing 2020
Oct 9, 2020
35408_dirs_2020-10-08_193bd412-db42-424f-b656-d4833a383d04.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 3 — Initial Statement of Beneficial Ownership
Issuer: SPRUCE BIOSCIENCES, INC. (SPRB)
CIK: 0001683553
Period of Report: 2020-10-08
Reporting Person: SPIEGELMAN DANIEL K (Director)
Holdings (Derivative)
| Security | Exercise Price | Expiration | Underlying | Shares | Ownership |
|---|---|---|---|---|---|
| Stock Option (Right to Buy) | $7.52 | 2030-09-08 | Common Stock (34398) | Direct |
Footnotes
F1: The shares subject to the stock option are early exercisable, subject to the Issuer's right of repurchase, and vest over a three-year period commencing September 3, 2020, with 1/36th of the shares vesting on a monthly basis.
More from SPRUCE BIOSCIENCES, INC.
Regulatory Filings
2026
May 26
Regulatory Filings
2026
May 13
Regulatory Filings
2026
Apr 21
Regulatory Filings
2026
Apr 20
Annual Report
2026
Apr 9
Proxy Solicitation & Information Statement
2026
Apr 9
Regulatory Filings
2026
Mar 20
Major Shareholding Notification
2026
Feb 17
Major Shareholding Notification
2026
Feb 17
Major Shareholding Notification
2026
Feb 17